Histamine receptors as potential therapeutic targets to treat anxiety and depression

Drug Development Research

Volumn 65, Issue 3, 2005, Pages 126-132

  Raber, Jacob ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Arginine vasopressin; Corticotropin releasing hormone; Elevated plus maze; Elevated zero maze; Hypothalamic pituitary adrenal axis

Indexed keywords

CHLORPHENIRAMINE; CIMETIDINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTAMINE RECEPTOR; HISTIDINE; METODICLOROFEN; THIOPERAMIDE; ZOLANTIDINE;

ANXIETY; BEHAVIOR DISORDER; COGNITION; COGNITIVE DEFECT; DEPRESSION; HISTAMINE RELEASE; HUMAN; LIGAND BINDING; LOCOMOTION; REVIEW; SIGNAL TRANSDUCTION; WAKEFULNESS;

EID: 28444440221     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.20015     Document Type: Review

References (50)

1. Airaksinen M, Paetau A, Paljarvi K, Reinikainen K, Riekkinen P, Suomalainen R, Panula P. 1991. Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseases brains. Neuroscience 44:465-481.
2. Bhatnagar S, Sun L, Raber J, Maren S, Julius D, Dallman M. 2004. Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor. Physiol Behav 81:545-555.
3. Billings R, Tang S, Rakoff V. 1981. Depression associated with cimetidine. Can J Psychiatr 26:260-261.
4. -/- mice. Neuropsychopharmacology 29:441-449.
5. Borsini F, Meli A. 1988. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychoparmacology 94:147-160.
6. Brown RE, Stevens DR, Haas HL. 2001. The physiology of brain histamine. Prog Neurobiol 63:637-672.
7. Clark EA, Hill SJ. 1996. Sensitivity of histamine H3 receptor agonist-stimulated [35S]GTP gamma[S] binding to pertussis toxin. Eur J Pharmacol 296:223-225.
8. Coge F, Guenin SP, Rique H, Boutin JA, Galizzi JP. 2001. Structure and expression of the human histamine H4-receptor gene. Biochem Biophys Res Commun 284:301-309.
9. Delini-Stula A, Radeke E, van Riezen H. 1988. Enhanced functional responsiveness of the dopaminergic system-the mechanism of anti-immobility effects of antidepressants in the behavioural despair test in the rat. Neuropharmacology 27:943-947.
10. Frisch C, Hasenohrl R, Krauth J, Huston J. 1998. Anxiolytic-like behavior after lesion of the tuberomammilary nucleus E2-region. Exp Brain Res 119:260-264.
11. Garcia M, Floran B, Arias-Montano JA, Young JM, Aceves J. 1997. Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata. Neuroscience 80:241-249.
12. Hasenohrl RU, Weth K, Huston JP. 1999. Intraventricular infusion of the histamine H1 receptor antagonist chlorpheniramine improves maze performance and has anxiolytic-like effects in aged Fischer 344XBrown Norway rats. Exp Brain Res 128: 435-440.
13. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, Haas HL. 1997. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 49:253-278.
14. Imaizumi M, Onodera K. 1993. The behavioral and biochemical effects of thioperamide, a histamine H3- receptor antagonist, in a light/dark test measuring anxiety in mice. Life Sci 53: 1675-1683.
15. Izumi H, Makino Y, Shirakawa K, Garfield RE. 1995. Role of nitric oxide on vasorelaxation in human umbilical artery. Am J Obstet Gynecol 172:1477-1484.
16. John J, Wu M, Siegel J. 2004. Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior. Neuron 42:619-634.
17. Kalivas P. 1982. Histamine-induced arousal in the conscious and pentobarbital-pretreated rats. J Pharmacol Exp Therapeutic 222:37-42.
18. Kano M, Fukudo A, Tahshiro A, Utsumi A, Tamura D, Itoh M, Iawata R, Tashiro M, Mochizuki H, Funaki Y, Kato M, Hango M, Yanai K. 2004. Decreased histamine H1 receptor binding in the brain of depressed patients. Eur J Neurosci 20:803-810.
19. Killcross S, Robbins TW, Everitt BJ. 1997. Different types of fear-conditioned behaviour mediated by separate nuclei within amygdala. Nature 388:377-380.
20. Lader M, Scotto J-C. 1998. A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder. Psychopharmacology 139:402-406.
21. Lamberti C, Ipponi A, Bartolini A, Schunack W, Malmberg-Aiello P. 1998. Antidepressant-like effects of endogenous histamine and of two histamine H1 receptor agonists in the mouse forced swim test. Br J Pharmacol 123:1331-1336.
22. Li H, Burkhardt C, Heinrich UR, Brausch I, Xia N, Forstermann U. 2003. Histamine upregulates gene expression of endothelial nitric oxide synthase in human vascular endothelial cells. Circulation 107:2348-2354.
23. Lin J, Sakai K, Jouvet M. 1994. Hypothalamo-preoptic histaminergic projections in sleep-wake control in the cat. Eur J Neurosci 6:618-625.
24. Llorca P, Spadone C, Sol O, Danniau A, Bougerol T, Corruble E, Faruch M, Macher J, Sermet E, Servant D. 2002. Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: 1 3-month double-blind study. J Clin Psychiatr 63:1020-1027.
25. Malmberg-Aiello P, Ipponi A, Bartolini A, Schunack W. 2002. Mouse light/dark box test reveals anxiogenic-like effects by activation of histamine H1 receptors. Pharmacol Biochem Behav 71:321-326.
26. Monti J. 1993. Involvement of histamine in the control of the waking state. Life Sci. 53:1331-1338.
27. Nakagawa Y, Reed L, Nakamura M, McIntosh TK, Smith DH, Saatman KE, Raghupathi R, Clemens J, Saido TC, Lee VM-Y, Trojanowski J. 2000. Brain trauma in aged transgenic mice induces regression of established Ab Deposits. Exp Neurol 163:244-252.
28. Nath C, Gulati A, Dhawan K, Gupta G. 1988. Role of central histaminergic mechanism in behavioural depression (swimming despair) in mice. Life Sci. 42:2413-2417.
29. Noguchi S, Fukuda Y, Inukai T. 2002. Possible contributory role of the central histaminergic system in the forced swimming model. Arzneimittel- Forschung 42:611-613.
30. Oda T, Morikawa N, Saito Y, Masuho Y, Masumoto S. 2000. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 275:36781-36786.
31. O'Neill K, Gertner S. 1986. Effects of centrally administered H2 antagonists in the behavioral despair test. Psychoparmacology 90:190-192.
32. Parmentier R, Ohtsu H, Djebbara-Hannas Z, Valatx J-L, Watanabe T, Lin J-S. 2002. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 22:7695-7711.
33. Perez-Garcia C, Morales L, Cano MV, Sancho I, Alguacil LF. 1999. Effects of histamine H3 receptor ligands in experimental models of anxiety and depression. Psychopharmacology 142: 215-220.
34. Privou C, Knoche A, Hasenohrl RU, Huston JP. 1998. The H1- and H2-histamine blockers chlorpheniramine and ranitidine applied to the nucleus basalis magnocellularis region modulate anxiety and reinforcement related processes. Neuropharmacology 37: 1019-1032.
35. Raber J. 1998. Detrimental effects of chronic hypothalamic-pituitary- adrenal axis activation-From obesity to memory deficits. Mol Neurobiol 18:1-22.
36. Rizk A, Curley J, Robertson J, Raber J. 2004. Anxiety and cognition in histamine H3-receptor -/- mice. Eur J Neurosci 19:1-5.
37. -/- mice. Neurobiol Aging 26:637-643.
38. Saper C, German D. 1987. Hypothalamic pathology in Alzheimer's disease. Neurosci Lett 74:364-370.
39. Schlicker E, Betz R, Gothert M. 1988. Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn Schmiedebergs Arch Pharmacol 337:588-590.
40. Schlicker E, Schunack W, Gothert M. 1990. Histamine H3 receptor-mediated inhibition of noradrenaline release in pig retina discs. Naunyn Schmiedebergs Arch Pharmacol 342:497-501.
41. Schlicker E, Fink K, Detzner M, Gothert M. 1993. Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors. J Neural Transm Gen Sect 93:1-10.
42. Silver RB, Mackins CJ, Smith NC, Koritchneva IL, Lefkowitz K, Lovenberg TW, Levi R. 2001. Coupling of histamine H3 receptors to neuronal Na+/H+ exchange: a novel protective mechanism in myocardial ischemia. Proc Natl Acad Sci USA 98: 2855-2859.
43. Simpson J, Yates C, Watts A, Fink G. 1988. Congo red birefringent structures in the hypothalamus in senile dementia of the Alzheimer type. Neuropath App Neurobiol 14:381-393.
44. Song C, Earley B, Leonard B. 1996. Behavioural and immunological effects of the antihistamine terfenadine in olfactory bulbectomized rats. Eur Neuropsychopharmacol 6:157-162.
45. 3 receptors. Mol Pharmaco 2002:389-397.
46. Tseng BP, Esler WP, Clish CB, Stimson ER, Ghilardi JR, Vinters HV, Mantyh PW, Lee JP, Maggio JE. 1999. Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations. Biochemistry 38:10424-10431.
47. Wieland K, Bongers G, Yamamoto Y, Hashimoto T, Yamatodani A, Menge WM, Timmerman H, Lovenberg TW, Leurs R. 2001. Constitutive activity of histamine h(3) receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H(3) antagonists. J Pharmacol Exp Ther 299:908-914.
48. 1 receptors in mice: behavioral and neurochemical characterization. Life Science 62:1607-1610.
49. Yuzurihara M, Ikarashi Y, Ishige A, Sasaki H, Kuribara H, Marayuma Y. 2000. Effects of drugs acting as histamine releasers or histamine receptor blockers on an experimental anxiety model in mice. Pharmacol Biochem Behav 67:145-150.
50. Zawilska J, Nowak J. 1985. Alteration of histamine metabolism in the rat brain under influence of various antidepressive treatments. Agents Actions 16:105-108.